Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy

著录项

• 来源
  《Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research》 |2014年第5期|共4页
• 作者

  Das Sudipto; Vital Edward M.; Horton Sarah; Bryer Domini; El-Sherbiny Yasser; Rawstron Andrew C.; Ponchel Frederique; Emery Paul; Buch Maya H.;

  展开▼
• 作者单位

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 免疫性疾病;
• 关键词

• 入库时间 2022-08-18 10:16:33